释放政策红利 让健康福祉“看得见、摸得着”

Core Viewpoint - The article emphasizes the transformative impact of policy innovations in Hainan's Free Trade Port, particularly in the application of real-world clinical data to expedite the approval of innovative drugs and medical devices for domestic patients [2]. Group 1: Policy Innovations - Hainan is collaborating with the National Medical Products Administration to utilize clinical data from the LECON Special Zone to support domestic registration and market entry of medical products [2]. - The approach represents a significant shift in regulatory concepts and systems, moving beyond mere data collection to integrating real-world evidence into the registration review process [2]. Group 2: Impact on Healthcare - The policy innovations are translating into tangible health benefits for the public, making essential medications more accessible and expediting their approval [2]. - The collaborative efforts among various government departments and agencies are driving continuous institutional innovation, enhancing the overall healthcare landscape in Hainan [2].